Due to rapid growth in the senior population, the prevalence of age-associated diseases such as diabetes, liver, and kidney diseases are expected to increase significantly. The diagnosis and management of such diseases are responsible for the increasing number of prescriptions for tests such as creatinine, albumin, glucose, ketones, and bilirubin, etc. These tests are performed by urinalysis; hence, it is expected to have a positive impact on this market.
The availability of refurbished instruments acts as a challenge in the growth of this market as these instruments offer the same functionalities as new equipment at a lower cost. Several end users, mainly small and medium-sized laboratories, opt for cost-effective and refurbished systems.
𝐆𝐞𝐭 𝐌𝐨𝐫𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐆𝐫𝐚𝐛 𝐏𝐃𝐅 @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153479294
The market is segmented into disease screening and pregnancy and fertility. In 2020, the disease screening segment accounted for the largest share. This can be attributed to the increasing incidence of UTIs, diabetes, liver diseases and kidney ailments worldwide.
The urinalysis market is segmented into pregnancy & fertility tests, biochemical urinalysis and sediment urinalysis, based on test type. In 2020, the pregnancy & fertility segment accounted for the largest share. This can be attributed to the rising demand for fast & self-contained tests, the growing incidence of infertility disorders, the availability of decentralized diagnostic tests over time-consuming laboratory tests, and the global rise in first-time pregnancies worldwide.
The increasing burden of UTIs, diabetes, and kidney & liver diseases; rising geriatric population and the subsequent increase in age-associated diseases and increasing adoption of POC diagnostic tests are factors supporting the growth of this market. Growth opportunities in emerging economies provide lucrative opportunities for the players operating in the urinalysis market.
Read Press Release @ https://www.prnewswire.com/news-releases/urinalysis-market-worth-4-9-billion-by-2026--exclusive-report-by-marketsandmarkets-301356911.html